• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ThailandChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
The Risks of Associated Systemic and Atopic Comorbidities with AD
Dermatology
5 min
expert video

The Risks of Associated Systemic and Atopic Comorbidities with AD

What Could Remission Mean in AD?
Dermatology
1 min
expert video

What Could Remission Mean in AD?

Most Burdensome Symptoms Rated by PN Patients
Dermatology
1 min
expert video

Most Burdensome Symptoms Rated by PN Patients

Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone
Dermatology
5 min
expert video

Normalizing Skin Barrier by Inhibiting IL-4 & IL-13, or IL-13 Alone

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline
Pulmonology
4 min
videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

Importance of Achieving Disease Control in Adults With Moderate-to-Severe AD
Dermatology
20 min
expert video

Importance of Achieving Disease Control in Adults With Moderate-to-Severe AD

Skin Dyspigmentation In Prurigo Nodularis (PN)
Dermatology
10 min
interactivity

Skin Dyspigmentation In Prurigo Nodularis (PN)

GOLD Diagnosis and Assessment of COPD
Pulmonology
4 min
expert video

GOLD Diagnosis and Assessment of COPD

The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population
Dermatology
10 min
Infographic

The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population

Connecting Type 2 Inflammation to CRSwNP
Rhinology
1 min
expert video

Connecting Type 2 Inflammation to CRSwNP

Managing Type 2 Inflammatory Diseases: Multidisciplinary Frame of Mind
Type 2 Inflammation
6 min
expert video

Managing Type 2 Inflammatory Diseases: Multidisciplinary Frame of Mind

    1
    ...
    202122